Saturday 17 October 2026
Export KIDS’s income statement to Excel — free account
OrthoPediatrics Corp.
KIDS Healthcare Medical Devices
OrthoPediatrics Corp.’s revenue for fiscal 2025 (year ended December 2025) was $236.3 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 15.4%, EPS was flat, free cash flow grew 77.6% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.
21.95
0.62
−2.75%
Follow KIDS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 3 | 3 | 3 | 4 | 5 | 2 | 3 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,024.25 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | 0.75 | 8.40 | 10.36 | 4.92 | 8.49 | 10.12 | 7.18 | 2.71 | 1.49 |
P/S ratio |
0.77 | 1.91 | 7.62 | 9.47 | 10.48 | 11.76 | 6.94 | 5.03 | 2.61 | 1.76 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(6.49) | 1.61 | 4.05 | 5.24 | 3.20 | 2.93 | 9.36 | 7.30 | 3.84 | 2.68 |
Beneish M-Score |
— | (2.29) | (1.85) | 1.65 | (2.00) | (2.32) | (1.90) | (2.28) | (2.62) | (2.67) |
P/Operating CF |
100.23 | (26.27) | (160.68) | (99.22) | (4,744.28) | (933.93) | (253.90) | (99.23) | (134.17) | 40.26 |
P/B ratio |
0.00 | 1.84 | 5.36 | 4.83 | 3.17 | 5.12 | 2.24 | 1.99 | 1.51 | 1.20 |
Price to Tangible BV |
0.00 | 1.93 | 5.51 | 6.27 | 7.45 | 13.85 | 4.00 | 3.59 | 2.98 | 2.61 |
EV/Sales |
1.35 | 1.54 | 6.93 | 8.84 | 9.30 | 11.21 | 5.96 | 4.55 | 2.62 | 1.91 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(23.14) | (9.72) | (25.60) | (36.09) | (35.66) | (84.17) | (33.51) | (25.00) | (19.84) | (92.94) |
EV/FCF |
(5.95) | (5.10) | (18.95) | (21.48) | (22.15) | (37.82) | (19.80) | (14.69) | (12.36) | (24.95) |
Quick Ratio |
0.79 | 5.09 | 7.56 | 6.44 | 2.93 | 2.45 | 4.68 | 2.81 | 3.33 | 2.53 |
Current Ratio |
2.87 | 7.35 | 10.54 | 9.37 | 4.52 | 4.50 | 7.34 | 5.44 | 6.98 | 5.55 |
Net Debt/EBITDA |
(3.77) | 4.21 | 5.92 | 10.40 | 4.49 | 7.33 | 13.68 | 8.62 | (0.12) | (2.95) |
Debt/Assets |
57.17% | 30.93% | 18.98% | 14.38% | 0.37% | 0.34% | 0.21% | 2.29% | 15.32% | 19.10% |
Debt/Equity |
2.93 | 0.54 | 0.26 | 0.18 | 0.01 | 0.00 | 0.00 | 0.03 | 0.20 | 0.28 |
Asset Turnover |
2.43 | 0.81 | 0.59 | 0.49 | 0.28 | 0.31 | 0.33 | 0.34 | 0.45 | 0.48 |
Operating CF/Net income |
0.09 | 0.31 | 1.30 | 1.29 | 0.56 | 0.80 | (17.62) | 1.29 | 0.72 | 0.12 |
Capex/Depreciation |
(2.50) | (2.72) | (1.89) | (2.59) | (1.41) | (1.50) | (0.60) | (1.03) | (0.68) | (0.40) |
Interest Coverage |
(4.15) | (2.60) | (4.24) | (2.57) | (7.84) | (8.02) | (10.48) | 135.11 | (13.36) | (6.54) |
| 139.76% | 264.17% | (18.61%) | (12.25%) | (17.47%) | (7.07%) | 0.41% | (5.55%) | (10.34%) | (11.31%) | |
| (81.16%) | (41.65%) | (12.37%) | (9.33%) | (13.11%) | (5.21%) | 0.34% | (4.84%) | (8.29%) | (8.08%) | |
ROIC |
(17.47%) | (13.32%) | (14.11%) | (5.88%) | (11.10%) | (6.57%) | (6.11%) | (5.49%) | (6.14%) | (6.44%) |
Return on Tangible Assets |
(56.16%) | (33.38%) | (11.94%) | (10.12%) | (21.87%) | (12.28%) | 0.54% | (9.29%) | (14.90%) | (15.26%) |
Average Days of Receivables |
40.10 | 44.83 | 57.07 | 80.51 | 88.39 | 66.79 | 74.02 | 84.95 | 75.52 | 83.14 |
Research and Development Expense of Revenue |
5.96% | 7.50% | 8.22% | 7.92% | 7.42% | 5.65% | 6.91% | 7.33% | 5.39% | 3.85% |
Selling, General and Administrative Expense of Revenue |
75.85% | 82.20% | 82.53% | 79.87% | 98.72% | 87.44% | 85.04% | 84.80% | 81.61% | 81.47% |
Intangible Assets out of Total Assets |
0.04 | 0.03 | 0.02 | 0.18 | 0.42 | 0.47 | 0.39 | 0.38 | 0.37 | 0.37 |
Share Based Compensation of Revenue |
3.35% | 7.62% | 5.53% | 3.59% | 8.72% | 5.96% | 5.46% | 7.08% | 6.62% | 7.52% |
Graham Net Nets |
(0.26) | 0.40 | 0.15 | 0.13 | 0.10 | 0.05 | 0.21 | 0.22 | 0.22 | 0.23 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.06 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(18.97%) | (34.57%) | (2.75%) | (1.98%) | (4.39%) | (1.40%) | 0.10% | (2.79%) | (7.03%) | (9.52%) |
Free Cash Flow Yield |
(29.30%) | (15.76%) | (4.80%) | (4.34%) | (4.00%) | (2.52%) | (4.34%) | (6.15%) | (8.12%) | (4.34%) |
Revenue per Share |
21.39 | 11.36 | 4.58 | 4.96 | 3.94 | 5.09 | 5.91 | 6.56 | 8.87 | 10.07 |
Operating CF per Share |
(0.64) | (1.80) | (1.24) | (1.22) | (1.03) | (0.68) | (1.05) | (1.19) | (1.17) | (0.21) |
Capex per Share |
(2.73) | (1.63) | (0.43) | (0.83) | (0.63) | (0.83) | (0.48) | (0.84) | (0.62) | (0.47) |
Free Cash Flow per Share |
(3.37) | (3.43) | (1.67) | (2.04) | (1.65) | (1.51) | (1.54) | (2.03) | (1.79) | (0.68) |
Cash per Share |
0.92 | 10.60 | 4.83 | 4.93 | 4.72 | 2.85 | 5.78 | 3.63 | 3.07 | 2.68 |
Shareholders Equity per Share |
3.44 | 11.82 | 6.50 | 9.73 | 13.00 | 11.70 | 18.29 | 16.63 | 15.36 | 14.77 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.44 | 11.82 | 6.50 | 9.73 | 13.00 | 11.70 | 18.29 | 16.63 | 15.36 | 14.77 |
Free Cash Flow |
(5.87) | (13.76) | (21.05) | (29.85) | (29.83) | (29.07) | (31.80) | (46.03) | (41.31) | (15.96) |
Working Capital |
13.58 | 60.09 | 87.94 | 114.40 | 123.40 | 103.93 | 195.85 | 184.83 | 203.21 | 210.22 |
Capital Expenditures |
(4.75) | (6.54) | (5.46) | (12.09) | (11.30) | (16.01) | (10.03) | (18.98) | (14.26) | (11.11) |
Net Current Asset Value |
(3.86) | 34.76 | 66.78 | 88.27 | 72.79 | 54.74 | 177.64 | 164.78 | 118.53 | 94.39 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.13 | 0.14 | 0.09 | 0.17 | 0.16 | 0.16 | 0.08 | 0.13 | 0.07 | 0.05 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.22 | 0.23 | 0.23 | 0.22 | 0.29 | 0.37 | 0.49 | 0.45 | 0.41 | 0.56 |
Cash ROIC |
(23.36%) | (11.91%) | (12.86%) | (12.41%) | (9.29%) | (10.33%) | (6.37%) | (9.81%) | (8.30%) | (3.15%) |
Accounts Receivable Turnover |
7.69 | 9.41 | 7.88 | 5.80 | 4.28 | 5.58 | 5.72 | 5.01 | 5.32 | 4.91 |
Accounts Payable Turnover |
2.42 | 2.47 | 3.14 | 3.44 | 1.94 | 2.55 | 3.09 | 3.15 | 5.21 | 4.60 |
Inventory Turnover |
0.63 | 0.67 | 0.66 | 0.56 | 0.35 | 0.45 | 0.47 | 0.41 | 0.50 | 0.51 |
Average Days of Payables |
118.31 | 179.56 | 97.41 | 131.63 | 228.32 | 138.10 | 128.67 | 123.19 | 57.93 | 107.67 |
Days of Inventory on Hand |
466.21 | 637.13 | 630.65 | 773.43 | 1,205.27 | 852.58 | 902.34 | 1,030.86 | 760.87 | 766.77 |
Average Receivables |
4.85 | 4.85 | 7.30 | 12.50 | 16.61 | 17.58 | 21.37 | 29.71 | 38.49 | 48.10 |
Average Payables |
4.52 | 4.52 | 4.73 | 5.22 | 8.25 | 9.68 | 10.24 | 11.90 | 10.78 | 13.85 |
Average Inventory |
17.25 | 16.73 | 22.60 | 31.85 | 45.49 | 55.28 | 67.88 | 92.02 | 111.43 | 125.40 |
Average Assets |
15.34 | 56.49 | 97.20 | 147.13 | 251.28 | 312.34 | 366.00 | 433.24 | 455.98 | 490.92 |
Average Common Equity |
(8.91) | (8.91) | 64.61 | 112.05 | 188.56 | 230.07 | 302.01 | 377.84 | 365.80 | 350.58 |
Columns are period end dates